Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2020 Jul 23;19(9):1855–1863.e1. doi: 10.1016/j.cgh.2020.07.033

Table 1.

Demographic and Clinical Characteristics of Controls (No PI-IBS) and Cases (PI-IBS)

No PI-IBS
(n = 1079)
PI-IBS
(n = 301)
P value

Female, n (%) 437 (41) 185 (62) <.001
Age at time of infection, y, mean (SD) 46.0 (15) 42.6 (16) <.001
Caucasian, n (%) 971 (90) 275 (91) .48
Residence, n (%)a .006
 Urban 847 (79) 210 (70)
 Large rural 90 (8) 34 (11)
 Small rural 63 (6) 19 (6)
 Isolated rural 79 (7) 38 (13)
Acute gastroenteritis reported symptoms
 Diarrhea, n (%) 1012 (99.3) 281 (99.3) .97
 Diarrhea duration, d, means (SD) 8.0 (6) 9.1 (6) .013
 Diarrhea duration, n (%) <.001
  <3 d or NA 209 (19) 89 (30)
  3–7 d 531 (49) 116 (39)
  8–14 d 274 (25) 67 (22)
  >14 d 65 (6) 29 (10)
 Number of stools/d, means (SD) 16.9 (14) 19.4 (17) .016
 Bloody stools, n (%) 314 (31) 113 (40) .005
 Abdominal cramps, n (%) 840 (84) 256 (92) <.001
 Vomiting, n (%) 252 (25) 92 (33) .007
 Fever, n (%) 733 (73) 188 (67) .060
 Chills, n (%) 796 (80) 217 (79) .76
 Headache, n (%) 574 (58) 186 (67) .005
 Muscle aches, n (%) 562 (57) 157 (57) .88
 Joint pain, n (%) 353 (36) 100 (37) .76
Campylobacter species, n (%) .38
 C jejuni 939 (87) 251 (83)
 C coli 101 (9) 33 (11)
 Otherb 22 (2.0) 10 (3.3)
 Unknown 19 (1.8) 7 (2.3)
Quarter of specimen collection, n (%) .40
 January–March 200 (19) 47 (16)
 April–June 257 (24) 83 (28)
 July–September 386 (36) 111 (37)
 October–December 236 (22) 60 (20)
Hospitalization, n (%) 113 (11) 54 (18) <.001
Antibiotic use, n (%) 826 (78) 225 (76) .45
Days between symptom onset and antibiotic start, means (SD) 6.7 (9) 7.7 (7) .15
Time between symptom onset and antibiotic start, n (%) .042
 0–2 d 126 (12) 27 (9)
 3–9 d 488 (45) 116 (39)
 >9 d 126 (12) 48 (16)
 Unknown use/onset 104 (10) 38 (13)
 No antibiotic use 235 (22) 72 (24)
Antibiotic type, n (%)
 Fluoroquinolone 388 (36) 105 (35) .73
 Macrolide 403 (37) 106 (35) .50
 Metronidazole 75 (7) 22 (7) .83
 Combination of >1 134 (12) 39 (13) .80
 International travel before onset, n (%) 303 (29) 66 (23) .048
Contact with animals, n (%)
 Dogs 523 (58) 159 (62) .17
 Cats 216 (29) 80 (36) .055
 Nonpoultry birds 10 (1.6) 8 (4.1) .033
 Poultry 60 (9) 18 (9) .97
 Pigs 20 (3.1) 7 (3.6) .73
 Noncat/dog mammalian pets 21 (3.3) 9 (4.6) .39
 Reptiles/amphibians 9 (1.4) 4 (2.1) .53
 Ruminants 67 (10) 24 (12) .47
Food consumed the week before, n (%)
 Beef 561 (80) 138 (75) .16
 Chicken 730 (79) 204 (78) .75
 Turkey 140 (17) 39 (17) .95
 Pork 436 (48) 116 (46) .55
 Liver pate 21 (3.0) 4 (2.1) .51
 Well water 232 (24) 68 (25) .70
 Restaurant food 769 (77) 217 (78) .72

NOTE. Data were missing for the number of controls and cases, respectively, in the following variables: diarrhea, 60 and 18; diarrhea duration, 190 and 84; stools per day, 80 and 22; bloody stools, 73 and 19; abdominal cramps, 76 and 23; vomiting, 76 and 24; fever, 70 and 20; chills, 81 and 26; headache, 89 and 25; muscle aches, 86 and 26; joint pain, 92 and 29; antibiotics, 18 and 4; time from symptom onset to antibiotic use, 104 and 38; international travel, 30 and 14; contact with dogs, 171 and 46; cats, 330 and 76; nonpoultry birds, 446 and 108; poultry, 426 and 103; other mammalian pets, 439 and 105; reptiles/amphibians, 444 and 107; ruminants, 415 and 99; food consumed: beef, 376 and 117; chicken, 149 and 38; turkey, 248 and 67; pork, 170 and 48; liver pate, 372 and 110; water from a well, 122 and 33; restaurant week prior, 81 and 23. Boldface indicates P < .05.

NA, not applicable; IBS, irritable bowel syndrome; PI-IBS, postinfection irritable bowel syndrome; SD, standard deviation.

a

Classified using Rural/Urban Commuting Area–ZIP code approximation taxonomy.

b

Campylobacter species included the following: Campylobacter concisus, Campylobacter curvus, Campylobacter fetus, Campylobacter gracilis, Campylobacter hyointestinalis, Campylobacter lari, and Campylobacter upsaliensis.